Pilot Facility for Non-GMP Drug Substance Manufacturing

Gallus’ Princeton site has a designated pilot plant facility designed to serve as the final stage of process development, for engineering runs and for production of pre-clinical non-cGMP material at intermediate scale. The suite currently features 50 L and 200 L stainless steel bioreactors and a separated downstream purification suite for production of pre-clinical toxicology materials and reference standard.


  • 50 L and 200 L ABEC stainless steel bioreactors
  • 10 L to 200 L WAVE® Bioreactors for seed train scale up
  • Harvest by depth filtration
  • Multiple downstream processing skids
  • Uniflux 30 UF/DF skid